Active, not recruitingNCT03423953

Comprehensive Nano - Post Market Clinical Follow-Up Study

Studying Avascular necrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zimmer Biomet
Principal Investigator
Paola Vivoda
Zimmer Biomet
Intervention
Comprehensive Nano(device)
Enrollment
194 enrolled
Eligibility
18 years · All sexes
Timeline
20132030

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03423953 on ClinicalTrials.gov

Other trials for Avascular necrosis

Additional recruiting or active studies for the same condition.

See all trials for Avascular necrosis

← Back to all trials